Funded Tech Companies
Trevi Therapeutics
Trevi Therapeutics, based in New Haven, received equity investments through TPG Biotech, Lundbeckfond Ventures and Omega Funds.
Company Overview
Company Name
Trevi Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
195 Church St. 14th Floor
New Haven, CT 06510
USA
New Haven, CT 06510
USA
Phone
Website
Email Address
Company Background Information
Overview
Trevi Therapeutics, Inc. is a drug development company founded in 2011 focused on developing T111 for the severe chronic itching condition known as pruritus. Pruritus is manifested in various dermatological, metabolic, hematologic and neuronal conditions.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/21/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jennifer Good
Chief Financial Officer
Christopher Seiter
Chief Medical Officer
Thomas Sciascia
Vice President
Amale Hawi
VP - Bus. Development
Helena Brett-Smith
VP - Bus. Development
Yann Mazabraud
Company Investors
- TPG Biotech (Eran Nadav)
- Lundbeckfond Ventures
- Omega Funds
- New Enterprise Associates (Ed Mathers)
- Aperture Venture Partners
- Solar Capital (Anthony Storino)
- Square 1 Bank (Mara Huntington)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs